Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

RISK FACTORS

Topical glucocorticoids and risk of type 2 diabetes mellitus

A positive association between topical corticosteroid use and risk of type 2 diabetes mellitus has been reported in a large European population-based study. However, the increase in risk is small and should not influence the prescribing of topical corticosteroids when clinically indicated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. National Institute for Health and Care Excellence. Clinical knowledge summaries. Corticosteroids — oral. NICE https://cks.nice.org.uk/corticosteroids-oral#!scenarioRecommendation:3 (2017).

  2. Andersen, Y. M. F. et al. Association between topical corticosteroid use and type 2 diabetes in two European population-based adult cohorts. Diabetes Care https://doi.org/10.2337/dc18-2158 (2019).

    Article  PubMed  Google Scholar 

  3. Reynolds, R. M. et al. Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study. Eur. J. Endocrinol. 166, 861–868 (2012).

    Article  CAS  Google Scholar 

  4. Krejci-Manwaring, J. et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J. Am. Acad. Dermatol. 54, S235–S236 (2006).

    Article  Google Scholar 

  5. Lin, L.-K. et al. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res. Care 5, e000429 (2017).

    Article  Google Scholar 

  6. Donnelly, L. A., Morris, A. D. & Evans, J. M. M. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 100, 345–350 (2007).

    Article  CAS  Google Scholar 

  7. Leong, A. et al. Estimating the population prevalence of diagnosed and undiagnosed diabetes. Diabetes Care 36, 3002–3008 (2013).

    Article  Google Scholar 

  8. Geer, E. B., Islam, J. & Buettner, C. Mechanisms of glucocorticoid-induced insulin resistance. Endocrinol. Metab. Clin. North Am. 43, 75–102 (2014).

    Article  CAS  Google Scholar 

  9. Hengge, U. R. et al. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 54, 1–15 (2006).

    Article  Google Scholar 

  10. Milyani, A. A. & Al-Agha, A. E. Implication of topical steroids in the onset of osteoporosis. Case Rep. Pediatr. 2018, 4802172 (2018).

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. M. Reynolds.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johns, E.C., Reynolds, R.M. Topical glucocorticoids and risk of type 2 diabetes mellitus. Nat Rev Endocrinol 15, 379–380 (2019). https://doi.org/10.1038/s41574-019-0212-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-019-0212-8

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing